Delineating v-Src downstream effector pathways in transformed myoblasts
- PMID: 17637741
- DOI: 10.1038/sj.onc.1210665
Delineating v-Src downstream effector pathways in transformed myoblasts
Abstract
In this study, we delineate the intracellular signalling pathways modulated by a conditional v-Src tyrosine kinase that lead to unrestrained proliferation and block of differentiation of primary avian myoblasts. By inhibiting Ras-MAPK kinase and phosphatidylinositol 3-kinase with different means, we find that both pathways play crucial roles in controlling v-Src-sustained growth factor and anchorage independence for proliferation. The Ras-MAPK kinase pathway also contributes to block of differentiation independently of cell proliferation since inhibition of this pathway both in proliferating and growth-arrested v-Src-transformed myoblasts induces expression of muscle-specific genes, fusion into multinucleated myotubes and assembly of specialized contractile structures. Importantly, we find that the p38 MAPK pathway is inhibited by v-Src in myoblasts and its forced activation results in growth inhibition and expression of differentiation, indicating p38 MAPK as a critical target of v-Src in growth transformation and myogenic differentiation. Furthermore, we show that downregulation of p38 MAPK activation may occur via Ras-MAPK kinase, thus highlighting a cross-regulation between the two pathways. Finally, we report that the simultaneous inhibition of MAPK kinase and calpain, combined to activation of p38 MAPK, are sufficient to reconstitute largely the differentiation potential of v-Src-transformed myoblasts.
Similar articles
-
Insulin restores differentiation of Ras-transformed C2C12 myoblasts by inducing NF-kappaB through an AKT/P70S6K/p38-MAPK pathway.Oncogene. 2002 May 23;21(23):3739-53. doi: 10.1038/sj.onc.1205469. Oncogene. 2002. PMID: 12032842
-
v-Src inhibits myogenic differentiation by interfering with the regulatory network of muscle-specific transcriptional activators at multiple levels.Oncogene. 2003 Nov 13;22(51):8302-15. doi: 10.1038/sj.onc.1206915. Oncogene. 2003. PMID: 14614454
-
Stable expression of intracellular Notch suppresses v-Src-induced transformation in avian neural cells.Oncogene. 2007 May 17;26(23):3338-51. doi: 10.1038/sj.onc.1210124. Epub 2006 Dec 4. Oncogene. 2007. PMID: 17146440
-
G protein coupled receptor signaling through the Src and Stat3 pathway: role in proliferation and transformation.Oncogene. 2001 Mar 26;20(13):1601-6. doi: 10.1038/sj.onc.1204186. Oncogene. 2001. PMID: 11313907 Review.
-
Newest findings on the oldest oncogene; how activated src does it.J Cell Sci. 2004 Mar 1;117(Pt 7):989-98. doi: 10.1242/jcs.01111. J Cell Sci. 2004. PMID: 14996930 Review.
Cited by
-
MicroRNAs in skeletal myogenesis.Cell Cycle. 2011 Feb 1;10(3):441-8. doi: 10.4161/cc.10.3.14710. Epub 2011 Feb 1. Cell Cycle. 2011. PMID: 21270519 Free PMC article. Review.
-
Testing calpain inhibition in tumor endothelial cells: novel targetable biomarkers against glioblastoma malignancy.Front Oncol. 2024 Aug 2;14:1355202. doi: 10.3389/fonc.2024.1355202. eCollection 2024. Front Oncol. 2024. PMID: 39156707 Free PMC article.
-
Temporal analysis of reciprocal miRNA-mRNA expression patterns predicts regulatory networks during differentiation in human skeletal muscle cells.Physiol Genomics. 2015 Mar;47(3):45-57. doi: 10.1152/physiolgenomics.00037.2014. Epub 2014 Dec 29. Physiol Genomics. 2015. PMID: 25547110 Free PMC article.
-
Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.Invest New Drugs. 2015 Jun;33(3):641-51. doi: 10.1007/s10637-015-0229-3. Epub 2015 Mar 27. Invest New Drugs. 2015. PMID: 25809858 Clinical Trial.
-
Identification of c-Src tyrosine kinase substrates in platelet-derived growth factor receptor signaling.Mol Oncol. 2009 Dec;3(5-6):439-50. doi: 10.1016/j.molonc.2009.07.001. Epub 2009 Jul 10. Mol Oncol. 2009. PMID: 19632164 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous